Much progress has been made in understanding the mechanism of BIRC2 and BIRC3 in multiple cancers, including liver cancer, chronic lymphocytic leukaemia, breast cancer and ovarian cancer.10 This evidence concerns the gene BIRC2 and liver cancer.